Abstract
In vitro andin vivo studies revealed that pancreases of Long-Evans male rats metabolized 3-methylcholanthrene (3MC) principally at the 1- and 2-carbon positions. The pancreatic metabolizing capability was not induced by pretreatment with either benzo(a)pyrene (BP) or phenobarbital (PB). During the period of observation from 5 to 48 hr, the maximum tissue content of radioactivity observed in thein vivo studies occurred at 16 hr after injection of 3MC in both liver and pancreas. Pancreatic tissue retained about four times more carcinogen per gram of tissue than liver tissues at all time periods.
Similar content being viewed by others
References
NCHS. Vital Statistics of the United States. U.S. Department of Health, Education, and Welfare, Public Health Service, National Center of Health Statistics. Rockville, Maryland (annual editions through 1968)
Mancusco TF, El-Attar AA: Cohort study of workers exposed to betanaphthylamine and benzidine. J Occup Med 9:277–285, 1967
Black O, Webster PD: Uptake of methylcholanthrene in rat pancreas. Am J Dig Dis 19:37–42, 1974
Lavigne JG, Marchand C: Effects of phenobarbital pretreatment on rat pancreas. Am J Physiol 222:360–364, 1972
Iqbal ZM, Varnes ME, Yoshida A, Epstein SS: Metabolism of benz(a)pyrene by guinea pig pancreatic microsomes. Cancer Res 27:1011–1015, 1977
Black O: Histofluorescence of 3-methylcholanthrene metabolites in the rat pancreas. Gastroenterology 75:438–444, 1978
Sims P: The metabolism of 3-methylcholanthrene and some related compounds by rat-liver homogenates. Biochem J 98:215–228, 1966
Steel RGD and Torrie JH: Principles and Procedures of Statistics. McGraw-Hill, New York, 1960, p 73
Stoming TA, Geradot RJ: High pressure liquid chromatographic separation of the metabolites of 3-methylcholanthrene. Life Sci 20:113–116, 1977
Bresnick E, Liebelt RA, Stevenson JG, Madix JC: The distribution of radioactivity within the hepatic cell after administration of labeled 3-methylcholanthrene. Cancer Res 27:462–468, 1967
Levine WG, Singer RW: Hepatic intracellular distribution of foreign compounds in relation to their biliary excretion. J Pharmacol Exp Ther 183:411–419, 1972
Stoming TA, Bornstein W, Bresnick E: The metabolism of 3-methylcholanthrene by rat liver microsomes—a reinvestigation. Biochem Biophys Res Commun 79:461–469, 1977
Takahashi G, Yashuhira K: Excretion and conversion of 3-methylcholanthrene metabolites in the intestinal tract of the mouse. Cancer Res 32:710–715, 1972
Bürki K, Seibert RA, Bresnick E: Induction of benzpyrene hydroxylase activity in fetal rat liver implants. I. Metabolism of 3-methylcholanthrene and differential effects of its derivative on benzpyrene hydroxylase activity. Biochim Biophys Acta 260:98–110, 1972
Nebert DW, Gelboin HW: Thein vivo andin vitro induction of aryl hydroxylase in mammalian cells of different species, tissues, strains, and developmental and hormonal states. Arch Biochem Biophys 134:76–89, 1969
Bürki K, Liebelt AG, Bresnick E: Expression of aryl hydrocarbon hydroxylase induction in mouse tissuesin vivo and in organ culture. Arch Biochem Biophys 158:641–649, 1973
Chuang AHL, Bresnick E: Aryl hydrocarbon hydroxylase in mouse mammary gland. Cancer Res 36:4125–4129, 1976
Smith ER, Hagopian M: The uptake and secretion of 3-methylcholanthrene by the prostate gland of the rat and dog. J Natl Cancer Inst. 59:119–122, 1977
Author information
Authors and Affiliations
Additional information
This work was supported by the Medical Research Service of the Veterans Administration and Contract N01-CP-55656 with the National Cancer Institute.
Rights and permissions
About this article
Cite this article
Black, O., Murrill, E. & Fanska, C. Metabolism of 3-methylcholanthrene in rat pancreas. Digest Dis Sci 26, 358–363 (1981). https://doi.org/10.1007/BF01308379
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01308379